TSO

TriSourceObserve

Slow journalism for technology, industry, and capital.

Stories

Capital Flow

Shows how policy, balance sheets, market structure, and investor expectations transmit change across industries.

AllMacro InsightsCorporate StrategyFinTech & Future AssetsSector Deep-dive
TSO / High confidence
Capital FlowCorporate Strategy

ABC formally orders Grey’s Anatomy Texas spinoff, expected to premiere in mid-2027

ABC has confirmed a new Texas-set medical drama spinoff from Grey’s Anatomy. Three sources point to the same core facts: the project is being developed by Shonda Rhimes and current showrunner Meg Marinis, and ABC has given it a series order; one source adds that Ellen Pompeo is an executive producer, while another says it is expected to air in ABC’s midseason 2027 lineup. There are slight differences among the sources regarding the title, whether it was ordered straight-to-series, and the exact scheduling language.

May 23, 2026
Read analysis
TSO / High confidence
Capital FlowCorporate Strategy

Fervo Energy Completes US IPO Raising About $1.89 Billion, Nasdaq Debut Gains Around 33% to 35%

Fervo Energy completed an upsized US IPO, raising about $1.89 billion; its Nasdaq debut saw the stock rise roughly 33% to 35% intraday/after the open. Three sources consistently confirm the fundraising size and offer price, while the reported debut gain varies; references to AI and data center demand appear in only some sources.

May 19, 2026
Read analysis
TSO / High confidence
Capital FlowCorporate Strategy

HBO Max Releases First Trailer for Stuart Fails to Save the Universe and Sets Premiere for July 23, 2026

HBO Max has released the first trailer for the Big Bang Theory spinoff Stuart Fails to Save the Universe and announced that the series will premiere on July 23, 2026. Three sources consistently confirm the title, spinoff status, premiere date, and 10-episode count, though details vary slightly regarding the release timing, trailer reveal setting, and the event that sets the plot in motion.

May 16, 2026
Read analysis
TSO / High confidence
Capital FlowCorporate Strategy

Victoria’s Secret Faces Proxy Fight Ahead of Shareholders Meeting as Director Mariam Naficy Will Not Seek Re-Election

Victoria’s Secret disclosed ahead of its annual shareholders meeting that director Mariam Naficy will not seek re-election, while the company’s proxy fight with activist investor BBRC chairman Brett Blundy over board seats is intensifying. Confirmed information shows BBRC owns 13% of the company and has asked shareholders to vote “withhold” on board chair Donna James and Naficy. The company has also publicly laid out reasons for opposing Blundy’s entry to the board, but the details and background of those allegations vary across the three sources.

May 14, 2026
Read analysis
TSO / High confidence
Capital FlowCorporate Strategy

European Mid-Sized Pharma Firms Rapidly Acquire U.S. Biopharma Assets: Is a Cross-Border M&A Wave Underway?

From late April to early May, three European mid-sized pharmaceutical companies made successive moves in the U.S. biopharma sector: Chiesi acquired KalVista, Angelini bought Catalyst for about $4.1 billion, and Leo Pharma acquired Replay. The three sources point to a series of consecutive deals within the same time window, but they do not provide enough information to confirm whether this amounts to a “systematic buying trend” or to fully verify every deal term.

May 13, 2026
Read analysis
TSO / High confidence
Capital FlowCorporate Strategy

Cerebras Raises US IPO Price Range and Offering Size, with Three Sources Pointing to Stronger Demand

Cross-checked against Reuters, Bloomberg, and The Motley Fool, Cerebras Systems raised its US IPO price range to $150 to $160 per share in May 2026 and increased the number of shares on offer to 30 million. The three sources agree on the core terms, though they differ slightly in the timing of disclosure, wording, and how the fundraising amount is presented.

May 12, 2026
Read analysis